跳至主要内容
临床试验/NL-OMON46122
NL-OMON46122已完成不适用

Determine the feasibility of detecting endometriosis during surgery using a molecular targeted fluorescent imaging tracer - Detection of endometriosis using optical molecular imaging

niversitair Medisch Centrum Groningen0 个研究点目标入组 4 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Females aged * 18 years
  • 2. Scheduled for surgery for the treatment of endometriosis
  • 3. WHO performance score of 0-2
  • 4. Written informed consent
  • For female subjects who are of childbearing potential, are premenopausal with intact reproductive organs or are less than 2 years post-menopausal:
  • 4. A negative serum pregnancy test prior to receiving the second generation tracer
  • 5. Willing to ensure that she or her partner uses effective contraception during the trial and for 6 months thereafter.

排除标准

  • 1. Medical or psychiatric conditions that compromise the patient*s ability to give informed consent ;2. Pregnancy
  • 3. History of infusion reactions to Bevacizumab or other monoclonal antibody therapies
  • 4. Significant renal, cardiac, or pulmonary disease (ASA III-IV)

研究者

相似试验

Determine the feasibility of detecting endometriosis... | 临床试验